Quince Therapeutics (QNCX) Goodwill & Intangibles (2022 - 2025)

Quince Therapeutics' Goodwill & Intangibles history runs 4 years deep, the most recent figure standing at $67.8 million for Q4 2025.

• In Q4 2025, Goodwill & Intangibles rose 12.95% year-over-year to $67.8 million; the TTM figure through Dec 2025 stood at $67.8 million (up 12.95% YoY), while the FY2025 annual figure was $67.8 million, up 12.95% from the prior year.
• Goodwill & Intangibles for Q4 2025 stood at $67.8 million, roughly flat from $67.7 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $80.8 million in Q4 2023, with the low at $5.9 million in Q3 2022.
• The 4-year median for Goodwill & Intangibles is $63.4 million (2024), against an average of $52.6 million.
• The sharpest annual moves came in 2023 and 2024: Goodwill & Intangibles jumped 1269.86% in 2023, then declined 25.71% in 2024.
• Quince Therapeutics' Goodwill & Intangibles stood at $5.9 million in 2022, then surged by 1269.86% to $80.8 million in 2023, then slipped by 25.71% to $60.0 million in 2024, then climbed by 12.95% to $67.8 million in 2025.
• Business Quant data shows QNCX's Goodwill & Intangibles at $67.8 million in Q4 2025, $67.7 million in Q3 2025, and $67.6 million in Q2 2025.